Aug 11, 2018 -
Aug 10, 2018 - Novo Nordisk (NVO) reports strong Q2 results. J&J (JNJ) seeks approval for new dosing regimen of multiple myeloma drug. Allergan (AGN) exercises option to buy Editas' lead ocular candidate.
Aug 01, 2018 -
Jul 26, 2018 - Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on iTunes, Stitcher and SoundCloud (click the highlighted links). The tech-heavy Nasdaq is set for a big down
Jul 25, 2018 - Vaccinex has filed proposed terms for a $45 million IPO of its common stock. The firm is developing potential treatments for Huntington's Disease and non-small cell lung cancer based on its VX15 candi
Jul 24, 2018 - Roche announces that the co-primary endpoint of progression-free survival in its phase 3 study treating patients with front-line advanced non-squamous non-small cell lung cancer had been met. The prog
Jul 24, 2018 - AstraZeneca (AZN) sells Atacand and Atacand Plus' European rights to Cheplapharm Arzneimittel for $210 million.
Jul 22, 2018 - SURF has a business-minded management with a strong track record of raising capital, shoring up its balance sheet with $200 million cash through its spring IPO and partnership w/ Novartis.The company'
Jul 17, 2018 - Ironwood (IRWD) commences a phase IIIb study in order to add a couple of new symptoms like bloating and discomfort associated with IBS-C to Linzess' label.
Jul 15, 2018 - Cytodyn announced it will acquire ProstaGene LLC. Novartis bows out of antibiotic development programs. Advaxis announced that FDA clinical hold for cervical cancer program had been removed.